BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28490870)

  • 1. Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.
    Sawalha S; Hedman L; Rönmark E; Lundbäck B; Lindberg A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1269-1277. PubMed ID: 28490870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study.
    Sawalha S; Hedman L; Backman H; Stenfors N; Rönmark E; Lundbäck B; Lindberg A
    Ther Adv Respir Dis; 2019; 13():1753466619860058. PubMed ID: 31291820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
    Tan DJ; Lodge CJ; Walters EH; Bui DS; Pham J; Lowe AJ; Bowatte G; Vicendese D; Erbas B; Johns DP; James AL; Frith P; Hamilton GS; Thomas PS; Wood-Baker R; Han MK; Washko GR; Abramson MJ; Perret JL; Dharmage SC
    Am J Respir Crit Care Med; 2024 Jun; 209(12):1431-1440. PubMed ID: 38236192
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.
    van den Bemt L; Wouters BC; Grootens J; Denis J; Poels PJ; Schermer TR
    NPJ Prim Care Respir Med; 2014 Aug; 24():14033. PubMed ID: 25119686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease.
    Nilsson U; Blomberg A; Johansson B; Backman H; Eriksson B; Lindberg A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2507-2514. PubMed ID: 28860744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
    Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P
    Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
    Buhr RG; Barjaktarevic IZ; Quibrera PM; Bateman LA; Bleecker ER; Couper DJ; Curtis JL; Dolezal BA; Han MK; Hansel NN; Krishnan JA; Martinez FJ; McKleroy W; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Kanner RE; Cooper CB;
    Am J Respir Crit Care Med; 2022 Sep; 206(5):554-562. PubMed ID: 35549640
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 11. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory medication use in primary care among COPD subjects in four Latin American countries.
    Jardim JR; Stirbulov R; Moreno D; Zabert G; Lopez-Varela MV; Montes de Oca M
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):458-465. PubMed ID: 28284262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
    Bhatt NY; Wood KL
    Drugs Aging; 2008; 25(9):717-28. PubMed ID: 18729545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care.
    Izbicki G; Teo V; Liang J; Russell GM; Holland AE; Zwar NA; Bonevski B; Mahal A; Eustace P; Paul E; Phillips K; Wilson S; George J; Abramson MJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2745-2752. PubMed ID: 31819406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
    Ghattas C; Dai A; Gemmel DJ; Awad MH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts.
    Perret JL; Vicendese D; Simons K; Jarvis DL; Lowe AJ; Lodge CJ; Bui DS; Tan D; Burgess JA; Erbas B; Bickerstaffe A; Hancock K; Thompson BR; Hamilton GS; Adams R; Benke GP; Thomas PS; Frith P; McDonald CF; Blakely T; Abramson MJ; Walters EH; Minelli C; Dharmage SC;
    BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34857526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?
    Perez-Padilla R; Vollmer WM; Vázquez-García JC; Enright PL; Menezes AM; Buist AS;
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):387-93. PubMed ID: 19275802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry.
    Lin SH; Kuo PH; Kuo SH; Yang PC
    Yonsei Med J; 2009 Oct; 50(5):672-6. PubMed ID: 19881971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.